The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Cholangiopancreatography, Endoscopic Retrograde

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cholangiopancreatography, Endoscopic Retrograde


High impact information on Cholangiopancreatography, Endoscopic Retrograde


Chemical compound and disease context of Cholangiopancreatography, Endoscopic Retrograde


Biological context of Cholangiopancreatography, Endoscopic Retrograde


Anatomical context of Cholangiopancreatography, Endoscopic Retrograde


Associations of Cholangiopancreatography, Endoscopic Retrograde with chemical compounds


Gene context of Cholangiopancreatography, Endoscopic Retrograde

  • The accumulation of p53 gene product to immunochemically detectable levels in ERCP brush samples also increases the sensitivity of conventional light microscopy [26].
  • The influence of the clinical course on procalcitonin (PCT), serum amyloid A (SAA), and several proinflammatory and inhibitory cytokines was evaluated in patients with AP following ERCP [27].
  • We adapted a clinically relevant surgical technique (endoscopic retrograde cholangiopancreatography) to deliver rAAV encoding human alpha1-antitrypsin (approved gene symbol SERPINA1) to the pancreas of 3-week-old Fisher 344 rats and C57BL/6 mice [28].
  • MATERIALS AND METHODS: The authors retrospectively reviewed MRCP and ERCP images obtained in 28 patients with mucin-producing pancreatic tumors [29].
  • RESULTS: K-ras mutations have been successfully detected in ERCP brush samples, leading to an increase of the sensitivity and improvement of the diagnostic yield [26].

Analytical, diagnostic and therapeutic context of Cholangiopancreatography, Endoscopic Retrograde


  1. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Oiofinlade, O. Gastroenterology (2004) [Pubmed]
  2. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. van den Hazel, S.J., Speelman, P., Dankert, J., Huibregtse, K., Tytgat, G.N., van Leeuwen, D.J. Ann. Intern. Med. (1996) [Pubmed]
  3. Correlation between pancreatic polypeptide response to secretin and ERCP findings in chronic pancreatitis. Stern, I., Roberts-Thomson, I.C., Hansky, J. Gut (1982) [Pubmed]
  4. Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression. Semelka, R.C., Kroeker, M.A., Shoenut, J.P., Kroeker, R., Yaffe, C.S., Micflikier, A.B. Radiology. (1991) [Pubmed]
  5. Adenocarcinoma of the cecum as the first manifestation of ulcerative colitis complicated by primary sclerosing cholangitis and endomyocardial fibrosis. Magro, F., Correia, M., Moreira, G., Dinis-Ribeiro, M., Amandio, V., Carneiro, F., Ribeiro, T. Inflamm. Bowel Dis. (2002) [Pubmed]
  6. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group. Cavallini, G., Tittobello, A., Frulloni, L., Masci, E., Mariana, A., Di Francesco, V. N. Engl. J. Med. (1996) [Pubmed]
  7. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Vargo, J.J., Zuccaro, G., Dumot, J.A., Shermock, K.M., Morrow, J.B., Conwell, D.L., Trolli, P.A., Maurer, W.G. Gastroenterology (2002) [Pubmed]
  8. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Devière, J., Le Moine, O., Van Laethem, J.L., Eisendrath, P., Ghilain, A., Severs, N., Cohard, M. Gastroenterology (2001) [Pubmed]
  9. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Murray, B., Carter, R., Imrie, C., Evans, S., O'Suilleabhain, C. Gastroenterology (2003) [Pubmed]
  10. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Binmoeller, K.F., Harris, A.G., Dumas, R., Grimaldi, C., Delmont, J.P. Gut (1992) [Pubmed]
  11. Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis. Mee, A.S., Girdwood, A.H., Walker, E., Gilinsky, N.H., Kottler, R.E., Marks, I.N. Gut (1985) [Pubmed]
  12. Carotenoids and tocopherols in various hepatobiliary conditions. Leo, M.A., Ahmed, S., Aleynik, S.I., Siegel, J.H., Kasmin, F., Lieber, C.S. J. Hepatol. (1995) [Pubmed]
  13. Local application of a potent vasoconstrictor during ERCP for the acute management of hemobilia. Wettstein, A.R., Meier, R. Am. J. Gastroenterol. (1998) [Pubmed]
  14. Acute cholangitis--predictive factors for emergency ERCP. Hui, C.K., Lai, K.C., Yuen, M.F., Ng, M., Lai, C.L., Lam, S.K. Aliment. Pharmacol. Ther. (2001) [Pubmed]
  15. Modification of endoscopic retrograde cholangiopancreatography (ERCP) septic complications by the addition of an antibiotic to the contrast media. Randomized controlled investigation. Collen, M.J., Hanan, M.R., Maher, J.A., Stubrin, S.E. Am. J. Gastroenterol. (1980) [Pubmed]
  16. A prospective, double-blind trial of L-hyoscyamine versus glucagon for the inhibition of small intestinal motility during ERCP. Lahoti, S., Catalano, M.F., Geenen, J.E., Hogan, W.J. Gastrointest. Endosc. (1997) [Pubmed]
  17. Assessment of pancreatic ductal penetration of antibiotics. Wallace, J.R., Johnson, J., Lucas, C.E., Cushing, R., Ledgerwood, A.M., Sugawa, C. The American surgeon. (1984) [Pubmed]
  18. Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis. Kemppainen, E., Hietaranta, A., Puolakkainen, P., Sainio, V., Halttunen, J., Haapiainen, R., Kivilaakso, E., Nevalainen, T. Pancreas (1999) [Pubmed]
  19. Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease. Carr-Locke, D.L. Gut (1980) [Pubmed]
  20. Endoscopic papillectomy: a novel approach to difficult cannulation. Farrell, R.J., Khan, M.I., Noonan, N., O'Byrne, K., Keeling, P.W. Gut (1996) [Pubmed]
  21. Clinical utility of intraductal US for evaluation of choledocholithiasis. Catanzaro, A., Pfau, P., Isenberg, G.A., Wong, R.C., Sivak, M.V., Chak, A. Gastrointest. Endosc. (2003) [Pubmed]
  22. Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis. Mariani, A., Curioni, S., Zanello, A., Passaretti, S., Masci, E., Rossi, M., Del Maschio, A., Testoni, P.A. Gastrointest. Endosc. (2003) [Pubmed]
  23. Reversibility of exocrine pancreatic failure in chronic pancreatitis. García-Pugés, A.M., Navarro, S., Ros, E., Elena, M., Ballesta, A., Aused, R., Vilar-Bonet, J. Gastroenterology (1986) [Pubmed]
  24. Retained common bile duct stones after endoscopic sphincterotomy: temporary and longterm treatment with biliary stenting. Maxton, D.G., Tweedle, D.E., Martin, D.F. Gut (1995) [Pubmed]
  25. Changes in glucose tolerance after endoscopic retrograde cholangiopancreatography. Tulassay, Z., Papp, J., Szathmári, M., Kisfaludy, S., Korányi, L., Tamás, G. Gut (1981) [Pubmed]
  26. Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. Tascilar, M., Caspers, E., Sturm, P.D., Goggins, M., Hruban, R.H., Offerhaus, G.J. Ann. Oncol. (1999) [Pubmed]
  27. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Oezcueruemez-Porsch, M., Kunz, D., Hardt, P.D., Fadgyas, T., Kress, O., Schulz, H.U., Schnell-Kretschmer, H., Temme, H., Westphal, S., Luley, C., Kloer, H.U. Dig. Dis. Sci. (1998) [Pubmed]
  28. Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts. Loiler, S.A., Tang, Q., Clarke, T., Campbell-Thompson, M.L., Chiodo, V., Hauswirth, W., Cruz, P., Perret-Gentil, M., Atkinson, M.A., Ramiya, V.K., Flotte, T.R. Mol. Ther. (2005) [Pubmed]
  29. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Koito, K., Namieno, T., Ichimura, T., Yama, N., Hareyama, M., Morita, K., Nishi, M. Radiology. (1998) [Pubmed]
  30. Effects of x-radiation on fibreoptic endoscopes. Ashby, B.S., Goodman, D.A. Gut (1980) [Pubmed]
  31. Intraductal mucin-producing tumors of the pancreas: imaging findings. Procacci, C., Graziani, R., Bicego, E., Bergamo-Andreis, I.A., Mainardi, P., Zamboni, G., Pederzoli, P., Cavallini, G., Valdo, M., Pistolesi, G.F. Radiology. (1996) [Pubmed]
  32. The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels. Bayraktar, Y., Balkanci, F., Ozenc, A., Arslan, S., Koseoglu, T., Ozdemir, A., Uzunalimoglu, B., Telatar, H., Gurakar, A., Van Thiel, D.H. Am. J. Gastroenterol. (1995) [Pubmed]
  33. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Tulassay, Z., Döbrönte, Z., Prónai, L., Zágoni, T., Juhász, L. Aliment. Pharmacol. Ther. (1998) [Pubmed]
  34. Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Grauer, L., Padilla, V.M., Bouza, L., Barkin, J.S. Am. J. Gastroenterol. (1993) [Pubmed]
WikiGenes - Universities